Bone mineral density in patients with prostatic cancer treated with orchidectomy and with estrogens.
prospective_cohort · Level II
Where this comes from
- Record sourced from PubMed, PMID 7584882.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Bone mineral density (BMD) and bone mineral content (BMC) were measured in the femoral neck area, trochanteric area and Wards triangle, and in the distal radius of the left forearm before and after 1 year of endocrine treatment in 27 patients with prostatic cancer. Eleven of the patients were treated with orchidectomy and 16 with combined oral and intramuscular estrogens. The patients were free from metastases during the entire observation period. In the orchidectomized patients, BMD and BMC of the distal radius decreased significantly following treatment, whereas no changes were observed in the estrogen-treated patients. These preliminary results demonstrate that estrogens may protect bone in male subjects also and may merit further investigations on larger groups of patients.
Medical subject headings
- Antineoplastic Agents, Hormonal
- Bone Density
- Estrogens
- Orchiectomy
- Prostatic Neoplasms